Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MARR S.p.A. (M6Z) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:M6ZMARR S.p.A.EUR 4.55EUR 322.31M17.02-44.23%HoldUnlock the DE:M6Z analyst price target with TipRanks PremiumDE:M6ZUnlock the DE:M6Z top-analyst price target with TipRanks Premium
IT:CPRDavide Campari-Milano SpAEUR 6.52EUR 11.83B28.3621.59%Strong BuyUnlock the IT:CPR analyst price target with TipRanks PremiumDE:M6Z vs IT:CPRUnlock the IT:CPR top-analyst price target with TipRanks Premium
IT:ORSOrsero SpAEUR 14.16EUR 249.39M10.02-17.00%Moderate BuyUnlock the IT:ORS analyst price target with TipRanks PremiumDE:M6Z vs IT:ORSUnlock the IT:ORS top-analyst price target with TipRanks Premium
IT:FFFine Foods & Pharmaceuticals N.T.M. SpAEUR 5.10EUR 124.66M-40.83-43.58%Moderate BuyUnlock the IT:FF analyst price target with TipRanks PremiumDE:M6Z vs IT:FFUnlock the IT:FF top-analyst price target with TipRanks Premium
IT:IWBItalian Wine Brands S.p.A.EUR 15.50EUR 146.54M10.41-28.24%Moderate BuyUnlock the IT:IWB analyst price target with TipRanks PremiumDE:M6Z vs IT:IWBUnlock the IT:IWB top-analyst price target with TipRanks Premium
IT:NWLNewPrinces S.p.A.EUR 25.22EUR 1.08B4.2246.63%Moderate BuyUnlock the IT:NWL analyst price target with TipRanks PremiumDE:M6Z vs IT:NWLUnlock the IT:NWL top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:M6ZMARR S.p.A.4.54-3.60-44.16%
IT:CPRDavide Campari-Milano SpA6.520.9917.83%
IT:ORSOrsero SpA14.16-2.33-14.13%
IT:FFFine Foods & Pharmaceuticals N.T.M. SpA5.10-4.04-44.21%
IT:IWBItalian Wine Brands S.p.A.15.50-5.56-26.39%
IT:NWLNewPrinces S.p.A.25.227.8845.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts